MedTrace Logo

High Intensity Focused Ultrasound in Uterine Myoma

NCT03328260 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2020-01-03

No results posted yet for this study

Summary

Aim to evaluate the efficacy of safety of newly developed, high intensity focused ultrasound device in women with symptomatic uterine leiomyoma

Conditions

  • Uterine Leiomyoma

Interventions

DEVICE

HIFU

Transvaginal high intensity focused ultrasound to ablate uterine myoma

Sponsors & Collaborators

  • ALPINION Medical Systems

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-12
Primary Completion
2018-08-31
Completion
2019-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03328260 on ClinicalTrials.gov